Literature DB >> 240848

Activation of guanylate cyclase from rat liver and other tissues by sodium azide.

H Kimura, C K Mittal, F Murad.   

Abstract

Sodium azide, hydroxylamine, and phenylhydrazine at concentrations of 1 mM increased the activity of soluble guanylate cyclase from rat liver 2- to 20-fold. The increased accumulation of guanosine 3':5'-monophosphate in reaction mixtures with sodium azide was not due to altered levels of substrate, GTP, or altered hydrolysis of guanosine 3':5'-monophosphate by cyclic nucleotide phosphodiesterase. The activation of guanylate cyclase was dependent upon NaN3 concentration and temperature; preincubation prevented the time lag of activation observed during incubation. The concentration of NaN3 that resulted in half-maximal activation was 0.04 mM. Sodium azide increased the apparent Km for GTP from 35 to 113 muM. With NaN3 activation the enzyme was less dependent upon the concentration of free Mn2+. Activation of enzyme by NaN3 was irreversible with dilution or dialysis of reaction mixtures. The slopes of Arrhenius plots were altered with sodium azide-activated enzyme, while gel filtration of the enzyme on Sepharose 4B was unaltered by NaN3 treatment. Triton X-100 increased the activity of the enzyme, and in the presence of Triton X-100 the activation by NaN3 was not observed. Trypsin treatment decreased both basal guanylate cyclase activity and the responsiveness to NaN3. Phospholipase A, phospholipase C, and neuraminidase increased basal activity but had little effect on the responsiveness to NaN3. Both soluble and particulate guanylate cyclase from liver and kidney were stimulated with NaN3. The particulate enzyme from cerebral cortex and cerebellum was also activated with NaN3, whereas the soluble enzyme from these tissues was not. Little or no effect of NaN3 was observed with preparations from lung, heart, and several other tissues. The lack of an effect with NaN3 on soluble GUANYLATE Cyclase from heart was probably due to the presence of an inhibitor of NaN3 activation in heart preparations. The effect of NaN3 was decreased or absent when soluble guanylate cyclase from liver was purified or stored at -20degrees. The activation of guanylate cyclase by NaN3 is complex and may be the result of the nucleophilic agent acting on the enzyme directly or what may be more likely on some other factor in liver preparations.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 240848

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Increased guanylate cyclase activity is associated with an increase in cyclic guanosine 3',5'-monophosphate in left ventricular hypertrophy.

Authors:  J D Sadoff; P M Scholz; J Tse; H R Weiss
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Effects of manganese on cyclic GMP levels in the rat ductus deferens.

Authors:  K D Schultz; K Schultz; G Schultz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-07       Impact factor: 3.000

3.  Soluble bovine adrenal cortex guanylate cyclase: effect of sodium nitroprusside, nitrosamines, and hydrophobic ligands on activity, substrate specificity and cation requirement.

Authors:  C J Struck; H Glossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

4.  The effect of inhibitors of nitric oxide biosynthesis and cyclic GMP formation on nerve-evoked relaxation of human cavernosal smooth muscle.

Authors:  R S Pickard; P H Powell; M A Zar
Journal:  Br J Pharmacol       Date:  1991-11       Impact factor: 8.739

5.  Stimulation of human platelet guanylate cyclase by unsaturated fatty acid peroxides.

Authors:  H Hidaka; T Asano
Journal:  Proc Natl Acad Sci U S A       Date:  1977-09       Impact factor: 11.205

6.  Factors affecting the activity of guanylate cyclase in lysates of human blood platelets.

Authors:  A F Adams; R J Haslam
Journal:  Biochem J       Date:  1978-07-15       Impact factor: 3.857

7.  Guanylate cyclase activity in normal and diseased human muscle.

Authors:  C Cerri; N Canal; L Frattola
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-09       Impact factor: 10.154

8.  Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels.

Authors:  John E Baker; Jidong Su; Xiangping Fu; Anna Hsu; Garrett J Gross; James S Tweddell; Neil Hogg
Journal:  J Mol Cell Cardiol       Date:  2007-07-31       Impact factor: 5.000

9.  Activation of purified soluble guanylate cyclase by protoporphyrin IX.

Authors:  L J Ignarro; K S Wood; M S Wolin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

10.  Relationship between myoglobin contents and increases in cyclic GMP produced by glyceryl trinitrate and nitric oxide in rabbit aorta, right atrium and papillary muscle.

Authors:  T Ishibashi; M Hamaguchi; K Kato; T Kawada; H Ohta; H Sasage; S Imai
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.